@article{f80a73e6dec94493a3fafeb984a26c85,
title = "Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrative",
abstract = "With the rapid development of new, targeted therapies for the treatment of moderate/severe atopic dermatitis, it is opportune to review the available conventional systemic agents. We assess the published evidence for systemic therapies for atopic dermatitis and amalgamate this with real-world experience. Discussions are centred on when systemic therapy should be considered, which drug(s), what dose, how to sequence or combine these therapies, how long they should be continued for and what is considered success.",
keywords = "atopic dermatitis, atopic eczema, azathioprine, biologic therapies, ciclosporin, corticosteroids, methotrexate, mycophenolate, second-line therapy, small molecules, systemic treatment",
author = "Marius Rademaker and Karen Agnew and Megan Andrews and Christopher Baker and Peter Foley and Kurt Gebauer and Monisha Gupta and Rubel, {Diana M.} and Colin Somerville and John Sullivan and Wong, {Li Chuen}",
note = "Publisher Copyright: {\textcopyright} 2019 The Australasian College of Dermatologists",
year = "2020",
month = feb,
day = "1",
doi = "10.1111/ajd.13141",
language = "English",
volume = "61",
pages = "9--22",
journal = "Australasian Journal of Dermatology",
issn = "0004-8380",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1",
}